Organoids are becoming increasingly popular advanced cell-based model systems globally. The AOF(Australian Organoid Facility) is a strategic investment to utilize advanced automation systems to accelerate the uptake and broader use of organoids across Australia.
Revvity has built a trustful partnership with AOF at the University of Queensland previously by establishing the automation system to control the guided differentiation of stem cells. Dr. Nathan Gödde and Prof. Ernst J. Wolvetang from AOF shared their experiences of collaboration with Team Revvity Australia.
Watch our full video and learn how Revvity’s automation platform enables the AOF to establish a high level of quality control and reproducibility in the organoids that they produce.
For research use only. Not for use in diagnostics procedures.